🎥 @NazliDizman of @YaleIMed talks on modulating the gut microbiome to improve immune checkpoint inhibitor efficacy
Watch: 👉ow.ly/FZAb50KcrGK👈
@ASCO #ASCO22
VJ Oncology
22.7K posts
VJ Oncology
@VJOncology
The Video Journal of Oncology is dedicated to providing up-to-date information & international expertise on #Oncology #BCsm #LCsm #GUsm #GIsm #PCsm #CRCsm
Joined March 2016
- On the 2nd day of #ASCO22, we had the opportunity to speak to @DrJNaidoo from @Beaumont_Dublin, who discusses updates in the PACIFIC trial and her highlights in #lungcancer presented so far! Visit VJOncology.com to catch up on the latest at ASCO🔎 #LCSM #NSCLC @ASCO
- VIDEO: Speech & swallowing problems after #HeadandNeckCancer w/ Justin Roe of @royalmarsdenNHS ow.ly/2X1m50AoNLB @VJOncology @ASCO #VirtualMeeting #OncoAlert @OncoAlert #HNSCC
- VIDEO: HER2-E pCR with anti-HER2-based neoadjuvant therapies w/ @prat_aleix of @hospitalclinic: ow.ly/d3X050zRfLL @myESMO #BCsm #VirtualMeeting #BreastCancer #ESMOBreast20 #OncoAlert
- 🎥@BraunMDPhD of @YaleMed discusses the unique immune biology of kidney cancer and the need for targeted studies to understand resistance and improve anti-tumor immunity: ➡️ow.ly/XPv150PfZLK #KCSM #ASCO23 #ImmunoOnc
- VIDEO: The evolving role of the nurse in cancer therapy w/ Celia Diez de los Rios of @UHSFT: ow.ly/NCG130oybgN @myESMO @IASLC #ELCC19 #LCsm #LungCancer
- #ESMOBreast23 | Adrienne Waks @DFCI_BreastOnc shares how a combined analysis of 4 neoadjuvant studies reveals the predictive power of HER2DX test for treatment response in HER2-positive #BreastCancer Watch here: ow.ly/6u8r50One4i @myESMO #BCsm
- Day 1 in San Antonio for #SABCS22 ☀️ We caught up with @TomasPascualMD on the SOLTI-1503 PROMETEO Phase II trial of T-VEC + atezo in pts with residual #BreastCancer after neoadjuvant chemo! Coming soon on VJOncology.com @SABCSSanAntonio @AACR #BCsm #OncoAlert
- At #GI23 we spoke with @rachnatshroff who discussed latest treatment strategies for patients with biliary tract cancers 🎥 Watch here: ow.ly/HxAN50Mwvnm @ASCO #GIsm #CCA #BileDuctCancer
- VIDEO: MONARCH: Chemo-free options for triple-positive metastatic #BreastCancer w/ @E_de_Azambuja of @JulesBordet: ow.ly/GZTL50zZRyW @myESMO #BCsm #VirtualMeeting #ESMOBreast20 #OncoAlert
- We spoke with @YJanjigianMD (@MSKCancerCenter) at on updates in #MATTERHORN and #KEYNOTE811 shared at #GI24 Full interview will be published soon on @VJOncology! @ASCO #GastrointestinalCancer #GIsm #GCsm
- At #ESMOBreast21 we spoke w/ @ElisaAgostinett (@JulesBordet) on ROSALINE, a trial-in-progress for patients with lobular #BreastCancer 👩💻 Watch here! 👉ow.ly/1QI050EF5dP👈 @VJOncology @myESMO @OncoAlert #BCsm
- Yelena Y. Janjigian (@YJanjigianMD) of @sloan_kettering shares initial data from KEYNOTE-811 study of trastuzumab + chemotherapy with or without pembrolizumab for HER2+ metastatic G/GEJ cancer 👩⚕️📣 Watch here 👉ow.ly/xktf50Gi1EJ👈 @myESMO #WorldGI2021 #GIsm #Oncology
- Gil Morgan tells us about the joint @OncoAlert and @myESMO collaboration survey looking at ‘Social Media & Virtual Meetings in the #COVID19 Era’ Have your say here! 👉ow.ly/xWBb50Ay5wv👈 @weoncologists #OncoAlert @OncoAlert #VirtualMeeting @VJOncology
00:00
